GLGLENVIEW CAPITAL MANAGEMENT, LLC
Institutional investor · Portfolio as of Q4 2019
Top Holdings50 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
HCA HOLDINGS INC | 6M | $881.7M | 7.7% | $119.49 | +17.60% | 5 qtrssince 2018-Q4 | Increased 70 |
THE CIGNA GROUP | 4.2M | $854.1M | 7.5% | $158.75 | +16.50% | 5 qtrssince 2018-Q4 | Decreased 0 |
TENET HEALTHCARE CORP | 19.7M | $750.5M | 6.6% | $17.93 | +110.88% | 5 qtrssince 2018-Q4 | Increased 63 |
PARAMOUNT GLOBAL | 15.1M | $632.9M | 5.5% | — | — | 1 qtr | New 98 |
TAKEDA PHARMACEUTIC-SP ADR | 30.6M | $603.4M | 5.3% | $18.88 | -2.50% | 4 qtrssince 2019-Q1 | Increased 69 |
IQVIA HOLDINGS INC | 3.8M | $579.7M | 5.1% | $115.32 | +33.06% | 5 qtrssince 2018-Q4 | Increased 64 |
HOLOGIC INC | 10.1M | $525.6M | 4.6% | $43.06 | +20.43% | 5 qtrssince 2018-Q4 | Increased 71 |
MCKESSON CORP | 3.7M | $513.5M | 4.5% | $105.01 | +25.48% | 5 qtrssince 2018-Q4 | Decreased 0 |
BAUSCH HEALTH COS INC | 16.6M | $497.2M | 4.4% | $22.43 | +31.25% | 5 qtrssince 2018-Q4 | Increased 69 |
DXC TECHNOLOGY CO | 11M | $413M | 3.6% | $51.00 | -29.66% | 5 qtrssince 2018-Q4 | Decreased 0 |
HUMANA INC | 1.1M | $388.4M | 3.4% | $252.45 | +38.20% | 5 qtrssince 2018-Q4 | Decreased 0 |
FMC CORP | 3M | $302.7M | 2.6% | $52.60 | +58.28% | 5 qtrssince 2018-Q4 | Decreased 0 |
WALT DISNEY CO/THE | 2.1M | $302M | 2.6% | $125.88 | +11.59% | 4 qtrssince 2019-Q1 | Increased 60 |
ALPHABET INC-CL A | 219,919 | $294.6M | 2.6% | $51.94 | +27.99% | 5 qtrssince 2018-Q4 | Decreased 0 |
| 20.3M | $256.7M | 2.2% | $6.33 | +50.18% | 5 qtrssince 2018-Q4 | Increased 57 | |
NUANCE COMMUNICATIONS INC | 13.7M | $244.2M | 2.1% | — | — | 5 qtrssince 2018-Q4 | Increased 80 |
AVIS BUDGET GROUP INC | 7.2M | $232.1M | 2.0% | $26.49 | +17.21% | 5 qtrssince 2018-Q4 | Increased 78 |
ANTHEM INC | 751,142 | $226.9M | 2.0% | $239.87 | +17.35% | 5 qtrssince 2018-Q4 | Decreased 0 |
UNITEDHEALTH GROUP INC | 757,121 | $222.6M | 1.9% | $221.30 | +20.41% | 3 qtrssince 2019-Q2 | Increased 51 |
FISERV INC | 1.8M | $206.2M | 1.8% | $102.61 | +12.53% | 2 qtrssince 2019-Q3 | Decreased 0 |
GLENVIEW CAPITAL MANAGEMENT, LLC manages $11.4B across 50 positions as of Q4 2019. Top holdings: HCA (7.7%), CI (7.5%), THC (6.6%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 3.5/5.0.
Active quarter - 12 new positions, 11 exits, 15 increased. Top move: PARA (NEW, conviction 98). Portfolio: $11.4B across 50 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer